Pfizer Piotroski F Score

<div class='circular--portrait' style='background:#FF0F00;color: #FFFFF0;font-size:3em;padding-top: 38px;;'>PFE</div>
PFE -- USA Stock  

Trending

This module uses fundamental data of Pfizer to approximate its Piotroski F score. Pfizer F Score is determined by combining nine binary scores representing 3 distinct fundamental categories of Pfizer Inc. These three categories are profitability, efficiency, and funding. Some research analysts and sophisticated value traders use Piotroski F Score to find opportunities outside of the conventional market and financial statement analysis.They believe that some of the new information about Pfizer financial position does not get reflected in the current market share price suggesting a possibility of arbitrage. Please check Pfizer Altman Z Score, Pfizer Correlation, Pfizer Valuation as well as analyze Pfizer Alpha and Beta and Pfizer Hype Analysis.

Search Piotroski F Score

 
Refresh
The current year Issuance Repayment of Debt Securities is expected to grow to about 9.5 B, whereas Total Debt is expected to decline to about 51.7 B. Pfizer Calculated Tax Rate is expected to decrease significantly based on the last few years of reporting. The past year's Calculated Tax Rate was at 7.83. The current year Inventory Turnover is expected to grow to 1.59, whereas PPandE Turnover is expected to decline to 3.59.
5
Piotroski F Score -- Healthy
1
Current Return On Assets
Positive
2
Change in Return on Assets
Decreased
3
Cash Flow Return on Assets
Positive
4
Current Quality of Earnings (accrual)
Decreasing
5
Asset Turnover Growth
Increase
6
Current Ratio Change
Increase
7
Long Term Debt Over Assets Change
Lower Leverage
8
Change In Outstending Shares
Increase
9
Change in Gross Margin
No Change

Pfizer Piotroski F Score Drivers

Current ValueLast YearChange From Last Year 10 Year Trend
Weighted Average Shares6.8 B5.6 B
Fairly Up
Decreasing
Slightly volatile
Weighted Average Shares Diluted6.9 B5.7 B
Fairly Up
Decreasing
Slightly volatile
Net Cash Flow from Operations15.8 B12.6 B
Significantly Up
Decreasing
Stable
Total Assets189.4 B167.5 B
Moderately Up
Decreasing
Slightly volatile
Total Liabilities114.4 B104.3 B
Significantly Up
Increasing
Stable
Current Assets46.2 B32.8 B
Significantly Up
Decreasing
Slightly volatile
Current Liabilities31.9 B37.3 B
Fairly Down
Increasing
Slightly volatile
Total Debt51.7 B52.1 B
Slightly Down
Increasing
Slightly volatile
Return on Average Assets8.289.9556
Significantly Down
Increasing
Slightly volatile
Gross Margin75.5580.2531
Notably Down
Decreasing
Very volatile
Asset Turnover0.350.3166
Significantly Up
Increasing
Very volatile

Pfizer Inc F Score Driver Matrix

Current Sentiment - PFE

Pfizer Inc Investor Sentiment

Predominant part of Macroaxis users are at this time bullish on Pfizer Inc. What is your perspective on investing in Pfizer Inc? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

About Pfizer Piotroski F Score

F-Score is one of many stock grading techniques developed by Joseph Piotroski, a professor of accounting at the Stanford University Graduate School of Business. It was published in 2002 under the paper titled Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers. Piotroski F Score is based on binary analysis strategy in which stocks are given one point for passing 9 very simple fundamental tests, and zero point otherwise. According to Mr. Piotroski's analysis, his F-Score binary model can help to predict the performance of low price-to-book stocks.

  Weighted Average Shares

PfizerCurrent Valuation Drivers

2014201520162017201820192020 (projected)
Revenue Per Employee633.52 K498.99 K545.9 K582.55 K580.6 K586.07 K655.69 K
Average Assets170.84 B164.94 B170.91 B170.32 B164.21 B162.39 B158.48 B
Earnings before Tax12.26 B8.95 B8.34 B12.26 B11.86 B17.66 B17.1 B
Average Equity75.92 B66.44 B62.17 B62.22 B68.67 B61.66 B63.18 B
Enterprise Value230.88 B235.06 B239.08 B257.07 B289.8 B266.7 B273.97 B
Free Cash Flow15.5 B13.19 B14.19 B14.59 B13.63 B9.99 B11.24 B
Invested Capital102.08 B84.64 B72.89 B78.83 B79.54 B87.01 B84.82 B
Tangible Asset Value90.33 B78.78 B64.52 B67.1 B70.8 B73.47 B73.9 B
Working Capital34.01 B14.4 B7.83 B10.71 B18.07 B(4.5 B)(4.62 B)
Interest Coverage13.7813.012.4214.6111.787.679.09
Calculated Tax Rate25.4922.213.45(73.539212)5.947.839.52
PPandE Turnover4.113.833.893.873.943.783.59
Receivables Turnover5.55.86.426.396.66.185.59
Inventory Turnover1.621.461.721.571.491.291.59
Operating Margin25.9819.3716.8424.4421.5819.9719.72
Return on Investment11.678.948.6711.8710.539.3811.02
Cash Flow Per Share2.682.352.622.752.772.272.24
Quick Ratio1.792.071.070.840.930.50.51
Book Value per Share11.2410.489.7811.9410.811.3410.64
Current Ratio2.671.491.251.351.570.880.9
Debt to Equity Ratio0.510.60.710.610.660.830.68
EBITDA Margin34.727.4724.8434.1533.1145.6837.74

About Pfizer Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Pfizer Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pfizer using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pfizer Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way. Please read more on our fundamental analysis page.
 2017 2018 2019 2020 (projected)
Receivables8.22 B8.03 B8.72 B10.38 B
Inventories7.58 B7.51 B8.28 B7.42 B


 
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page